Cognition and Clinical Trials Advancement and Methods PIA's - Measuring Clinically Meaningful Change in Preclinical AD Trials: New Approaches & Challenges

Measuring treatment effects in preclinical Alzheimer’s disease (AD) relies on sensitive cognitive metrics. This webinar focuses on challenges and opportunities for new approaches to establishing clinically meaningful change in trials of early AD.

Moderators: Erin Abner, Roosmarijn Jutten, Kathleen Welsh-Bohmer

Panelists: Mark Dubbelman, Kathy Liu, Lon Schneider, Eric Siemers

To register for the live event, please visit: